+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Onychomycosis Treatment Market by Drug Type, Active Ingredient, Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast to 2030- Product Image
Onychomycosis Treatment Market by Drug Type, Active Ingredient, Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast to 2030- Product Image
Sale

Onychomycosis Treatment Market by Drug Type, Active Ingredient, Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460360
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The onychomycosis treatment market is evolving rapidly with new therapies, technologies, and supply chain dynamics shaping competitive priorities for healthcare stakeholders worldwide. Senior decision-makers must understand how emerging treatment segments, evolving policy landscapes, and technological innovation interact to drive transformation and deliver sustainable patient outcomes.

Market Snapshot: Growth and Opportunity in Onychomycosis Treatment

The onychomycosis treatment market grew from USD 2.09 billion in 2024 to USD 2.29 billion in 2025. It is expected to continue growing at a CAGR of 9.17%, reaching USD 3.55 billion by 2030. This robust expansion is fueled by shifts in patient demand, regulatory changes, and the steady introduction of advanced pharmaceutical formulations and digital health modalities. Executive insight into this market is essential for investors and providers seeking to optimize resources and policy responses amid increased prevalence and therapeutic innovation.

Scope & Segmentation of the Onychomycosis Treatment Market

This market research report analyzes the following dimensions to deliver a comprehensive view of onychomycosis treatment dynamics:

  • Drug Type: Combination therapy, laser therapy, oral therapy, and topical therapy present diverse options tailored to disease stage, patient profile, and setting.
  • Active Ingredient: Includes compounds such as amorolfine, ciclopirox, efinaconazole, fluconazole, itraconazole, tavaborole, and terbinafine, each with unique efficacy and resistance characteristics.
  • Formulation: Creams, gels, nail lacquers, solutions, and tablet capsules optimize delivery across patient segments and settings.
  • Distribution Channel: Product access is enabled through hospital pharmacy, online pharmacy, and retail pharmacy networks, supporting both acute interventions and long-term care.
  • Treatment Setting: Home care, hospital inpatient, and outpatient clinic pathways accommodate a range of case severities and patient adherence needs.
  • Age Group: Spanning below 18 years, 18 to 65 years, and above 65 years, ensuring age-appropriate care strategies and dosing.
  • Gender: Analysis includes both female and male patient cohorts, providing insights into prevalence patterns and adherence.
  • Disease Severity: Segmentation covers mild to moderate, recurrent, and severe cases—each impacting therapeutic duration and complexity.
  • Regional Coverage: Trends and policies are explored across Americas (including key US states and Latin American countries), Europe, Middle East & Africa (major regional economies), and Asia-Pacific (with focus on rapidly growing markets).
  • Company Analysis: Profiles of leading enterprises, such as Novartis AG, Pfizer Inc., Bausch Health Companies Inc., Bayer AG, Sanofi S.A., Galderma S.A., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., and LEO Pharma A/S, are included.

Key Takeaways for Onychomycosis Treatment Market Leaders

  • Product portfolios are expanding beyond traditional oral antifungals to encompass combination therapies and device-enabled regimens that address unmet patient needs and drive differentiation.
  • Pharmaceutical and device innovators increasingly integrate digital platforms that enable real-time adherence monitoring and support for remote patient management, strengthening outcomes data generation.
  • Regulatory bodies are facilitating more rapid approvals for novel formulations while encouraging evidence of long-term safety and cost-effectiveness for formulary inclusion.
  • Robust collaboration between multinational manufacturers, domestic producers, and digital health technology partners is necessary to deliver localized solutions matched to regional demands and reimbursement structures.
  • Patient-centric market segmentation that addresses variable disease severity and demographic diversity is indispensable for optimizing clinical effectiveness and commercialization strategies.

Tariff Impact on Market Dynamics and Supply Chains

The 2025 US tariffs on pharmaceutical raw materials have introduced volatile input costs into the onychomycosis treatment supply chain. Manufacturers are leveraging near-shoring, strategic sourcing, and long-term supplier contracts to mitigate price pressures. Distributors and pharmacies face tighter margins, prompting a sharper focus on value demonstration for both branded and generic solutions. These adaptive responses underscore the sector’s drive toward supply chain resiliency, strategic agility, and reinforced partnerships.

Methodology & Data Sources

Findings are based on a blend of primary interviews with dermatology and supply chain stakeholders, secondary analysis of peer-reviewed literature, and validation against regulatory filings and proprietary databases. The research applies statistical triangulation and multivariate analysis to enable reliable segmentation by therapy, active ingredient, formulation, distribution channel, patient setting, and severity.

The Role of Onychomycosis Treatment Reports for Decision-Makers

  • Uncover actionable insights into emerging therapies, technology enablers, and competitive shifts across major global markets.
  • Inform R&D priorities, procurement choices, and strategic alliances by leveraging data-driven segmentation and real-world evidence.
  • Enhance risk management and operational agility by understanding regional policy trends and supply chain contingencies.

Conclusion

Senior leaders benefit from a clear, data-backed perspective on evolving onychomycosis treatment opportunities. By focusing on segment dynamics, regulatory trends, and adaptive innovation, organizations can position themselves for growth and improved patient care outcomes globally.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Onychomycosis Treatment Market, by Drug Type
8.1. Introduction
8.2. Combination Therapy
8.3. Laser Therapy
8.4. Oral Therapy
8.5. Topical Therapy
9. Onychomycosis Treatment Market, by Active Ingredient
9.1. Introduction
9.2. Amorolfine
9.3. Ciclopirox
9.4. Efinaconazole
9.5. Fluconazole
9.6. Itraconazole
9.7. Tavaborole
9.8. Terbinafine
10. Onychomycosis Treatment Market, by Formulation
10.1. Introduction
10.2. Cream
10.3. Gel
10.4. Nail Lacquer
10.5. Solution
10.6. Tablet Capsule
11. Onychomycosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Onychomycosis Treatment Market, by Treatment Setting
12.1. Introduction
12.2. Home Care
12.3. Hospital Inpatient
12.4. Outpatient Clinic
13. Onychomycosis Treatment Market, by Age Group
13.1. Introduction
13.2. 18 to 65 Years
13.3. Above 65 Years
13.4. Below 18 Years
14. Onychomycosis Treatment Market, by Gender
14.1. Introduction
14.2. Female
14.3. Male
15. Onychomycosis Treatment Market, by Disease Severity
15.1. Introduction
15.2. Mild to Moderate
15.3. Recurrent
15.4. Severe
16. Americas Onychomycosis Treatment Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Onychomycosis Treatment Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Onychomycosis Treatment Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Novartis AG
19.3.2. Pfizer Inc.
19.3.3. Bausch Health Companies Inc.
19.3.4. Bayer AG
19.3.5. Sanofi S.A.
19.3.6. Galderma S.A.
19.3.7. Johnson & Johnson Services, Inc.
19.3.8. Teva Pharmaceutical Industries Ltd.
19.3.9. Viatris Inc.
19.3.10. LEO Pharma a/S
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. ONYCHOMYCOSIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. ONYCHOMYCOSIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. ONYCHOMYCOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ONYCHOMYCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TOPICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AMOROLFINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CICLOPIROX, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY EFINACONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TAVABOROLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY NAIL LACQUER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY HOSPITAL INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY 18 TO 65 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ABOVE 65 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY BELOW 18 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY MILD TO MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY RECURRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 64. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 67. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 111. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 113. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 116. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 124. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 135. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 137. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 140. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 142. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 143. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 145. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 146. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 148. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 175. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 180. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 182. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 191. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 193. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 196. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 198. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 204. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 206. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 223. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 225. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 226. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 228. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 231. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 233. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 236. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 238. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 252. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 254. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 255. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 257. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 258. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 260. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 262. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 280. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 282. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 285. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 287. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 288. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 290. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 291. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 293. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 295. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 296. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 298. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 299. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 301. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 303. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 328. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 329. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Onychomycosis Treatment market report include:
  • Novartis AG
  • Pfizer Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Sanofi S.A.
  • Galderma S.A.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • LEO Pharma A/S

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.55 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual, White Superficial, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual, White Superficial, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 140 Pages
  • Global
From
Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033 - Product Image

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 126 Pages
  • Global
From
Onychomycosis Treatment Market Report 2025 - Product Image

Onychomycosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Dermatophytic Onychomycosis Treatment - Global Strategic Business Report - Product Image

Dermatophytic Onychomycosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From

About the Onychomycosis Drug Market

Onychomycosis is a fungal infection of the nail, which is a common condition affecting the toenails and fingernails. It is caused by a variety of fungi, including dermatophytes, yeasts, and molds. Treatment of onychomycosis is typically done with antifungal drugs, which are part of the infectious diseases drugs market. These drugs are used to treat a variety of fungal infections, including onychomycosis. The onychomycosis drug market is composed of a variety of antifungal drugs, including topical and oral medications. Topical medications are applied directly to the affected nail, while oral medications are taken by mouth. These drugs are used to treat the infection and prevent it from spreading. The onychomycosis drug market is highly competitive, with many companies offering a variety of antifungal drugs. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. These companies offer a range of antifungal drugs, including topical and oral medications, to treat onychomycosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.